Conference Search Results
Search Criteria : Virology ×
Dec 07 - 08, 2020
International E-Conference on Virology, Infectious Diseases and COVID-19 is organized by United Research Forum (URF) and will be held from Dec 07 - 08, 2020. Theme: Awareness and knowledge on Viral Infections for healthy life Description International E-Conference on Virology, Infectious Diseases and COVID-19 "Virology Webinar 2020” is to bring together unique and international mix of experts, scientists, researchers and students to exchange and share their experiences and research outcomes on all elements of Virology, emerging Diseases. Additional details will be posted as soon as information is available.
Jul 01, 2015 - Jun 04, 2021 | Contact Hours : 2.5 | USD $24.95
Viral Hepatitis: New U.S. Screening Recommendations, Assessment Tools, and Treatments is organized by Wolters Kluwer. Published: Jul 2015 Expires: 6/4/2021 Credits: • ANCC 2.5 CH • DC - BON 2.5 CH • FL - BON 2.5 CH • GA - BON 2.5 CH Purpose of Activity: To provide information about the epidemiology and diagnosis of viral hepatitis, including components of the action plan of the U.S. Department of Health and Human Services. Topics: Chronic Disease , Hepatitis , Liver Overview: Over the past 15 years, the incidences of hepatitis A and B virus infection in the United States have declined significantly. By contrast, the incidence of hepatitis C virus infection, formerly stable or in decline, has increased by 75% since 2010. Suboptimal therapies of the past, insufficient provider awareness, and low screening rates have hampered efforts to improve diagnosis, management, and treatment of viral hepatitis. New screening recommendations, innovations in assessment and treatment, and an updated action plan from the U.S. Department of Health and Human Services (HHS) seem likely to lead to significant progress in the coming years. This article reviews the epidemiology, natural history, and diagnosis of viral hepatitis; discusses new screening recommendations, assessment tools, and treatments; and outlines the HHS action plan, focusing on the role of nurses in prevention and treatment. Learning Objectives/Outcomes: After completing this continuing education activity you will be able to: • Review the U.S. incidence and epidemiology of viral hepatitis. • Discuss new screening, treatment, and assessment guidelines for all types of viral hepatitis.
Nov 28, 2017 - Nov 28, 2020 | CME : 1 | USD $39.00
Zika Virus and Overview of Viral Infections in Pregnancy Course is organized by Intiva Health. Available: Nov 28, 2017 to Nov 28, 2020 Credit Offered: • 1 AMA PRA Category 1 Credit Credit • 1 AMA Certificate of Attendance Credit Learning Objectives: At the conclusion of this presentation, the practitioner will be able to: • Describe the material and fetal complications associated with Zika virus infection. • Describes the diagnostic algorithm for Zika virus infections. • Describe the maternal and fetal risks associated with varicella-zoster virus infection in pregnancy. • Describe the pathophysiology of congenital parvovirus infection. • Describe the best diagnostic tests for identifying congenital parvovirus infection. • Describe the appropriate antenatal and postpartum measures for prevention of neonatal hepatitis B infection
Jun 01, 2019 - Dec 31, 2022 | Credits : 2 | USD $32.00
An Introduction to the Herpes Viruses is organized by Dental Learning Systems, LLC. Released Date: Jun 01, 2019 Expired Date: Dec 31, 2022 Credits: 2 SI Learning Objectives: • Describe the symptoms of an active herpes infection. • Identify the signs of an active herpes infection. • Differentiate between herpes type 1, herpes type 2, varicella, and Epstein-Barr infections. • Discuss how the different herpes viruses are transmitted. • Identify which forms of herpes have available vaccines. • Summarize the principal complication of a “shingles” outbreak. Additional details will be posted as soon as information is available.
COVID Mini: The Disease is organized by Medmastery. Credits:- The certificate of this course comes with 1 CME credits. Description: Treating COVID-19 patients must begin with a solid understanding of how the virus works. In this mini-course, you'll learn to identify the most common symptoms and complications associated with COVID-19, a general timeline of disease progression, and the most common comorbidities that increase the risk of severe disease or death. After completing this course, you will be able to • Recognize the most common symptoms of COVID-19. • Identify risk factors for severe disease or mortality from COVID-19. • Appreciate the basic microbiological features of the SARS-CoV-2 virus, and how they relate to infection and possible future therapeutics. • Track the progression of COVID-19 over time in patients with mild, moderate, and severe illness. • Recognize potential non-respiratory complications associated with COVID-19 infection.
Dec 05 - 06, 2020 | CME : 11.5
2nd Advanced Lung Disease: Novel Therapies and Controversies Conference is organized by Baylor College of Medicine (BCM), Michael E. DeBakey Department of Surgery at Baylor College of Medicine. This Online CME Course will be held from Dec 05 - 06, 2020. Accreditation Texas Heart Institute is approved by the Accreditation Council for Continuing Medical Education to present continuing medical education for physicians. Credit Designation Texas Heart Institute assigns this online CME activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity. ABIM MOC Credit Successful completion of this CME activity, which involves participation in the evaluation component, allows the participant to earn up to 11.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Attendees will receive MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to proffer participant completion information to ACCME for the purpose of granting ABIM MOC credit. Course Description: The Advanced Lung Disease: Novel Therapies and Controversies Conference will have appealing state-of-the-art multidisciplinary lectures centered on the conditions diagnosis, prevention, and treatment of diseases affecting the lungs, along with the cystic fibrosis, COPD, Interstitial Lung Disease, pulmonary hypertension, and adult congenital heart diseases. The course will also feature panel sessions to provide clinicians the opportunity to discuss specific treatment challenges, the role of the caregivers, transplant coordinators, and logistics of transplantation and methods that will be useful in their practices. Advanced lung diseases affect a huge part of the population and provide significantly to morbidity and mortality. Novel therapies for diseases such as cystic fibrosis, COPD, Interstitial Lung Disease, pulmonary hypertension, and adult congenital heart diseases have furnished patients a chance at a new and healthier life. Transplantation is a significant part of the innovation for presenting these patients a new lease on life, but there are many steps and considerations along the way that can add to quality life years. The conference seeks to provide practitioners, trainees, patients, and associated staff with a look at the horizon of advanced lung therapies. Novel therapies such as ex vivo lung perfusion, airway stenting, biopsies, gene therapy, stem cells, bronchial valves, and lung volume reduction therapy will be addressed. Break out sessions will discuss the role of the caregivers, transplant coordinators, and logistics of transplantation. Additional details will be posted as soon as information is available.
| Credits : 1 | USD $40.00
Viruses: Something Old & Something New is organized by DO CME. Credits: 1 AOA Category 1-B Credit (AOMA) Course Description : Infectious disease is all around us. Dr. Joe Zachariah updates us on these contagious pathogens, what to look for, and treatment for infected patients. Course Objectives : • Differentiate the emergence of viruses in the United States • Diagnose viral diseases based on observed symptoms • Categorize appropriate testing for viral diseases Original Program Date: November 12, 2016 Access: Available for 3 months after purchase Additional details will be posted as soon as they are available.
| CE Credits : 2 | USD $30.00
An Introduction to the Herpes Viruses is organized by The American Dental Assistants Association (ADAA). Accreditation: CE Credits: 2 Course Description: The word herpes evokes an emotional response from almost everyone. Eighty to ninety-five percent of the world’s population has serological evidence of the herpes simplex virus type 1 (HSV-1, generally orolabial herpes), which often presents itself as a “cold sore” on the lip(s.) Only twenty-to-thirty percent of the U.S. population is seropositive for the herpes simplex virus type 2 (HSV-2, generally genital herpes) which is considered a sexually transmitted disease.1 Add childhood chickenpox, adult shingles, infectious mononucleosis, the immunosuppressant drugs used by cancer and organ-transplant patients, along with the increasing number of immunosuppressed patients who have HIV and AIDS, and it’s not hard to understand why we are now seeing a greater incidence of herpes infections. Learning Objectives: Upon completion of this course, the dental professional should be able to: • Describe the symptoms of an active herpes infection. • Identify the signs of an active herpes infection. • Differentiate between herpes type 1, herpes type 2, varicella, and Epstein-Barr infections. • Discuss how the different herpes viruses are transmitted. • Identify which forms of herpes have available vaccines. • Summarize the principal complication of a “shingles” outbreak. Original Release Date: 2010; Review Date: 2019; Expiration Date: 2022 Additional details will be posted as soon as information is available.
| Hours : 2 | USD $95.00
Mosquito-Borne Viral Diseases is organized by MediaLab, Inc. Accreditation: • P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 2 hour(s) Course number 578-095-18, approved through 12/31/2020 • Florida Board of Clinical Laboratory Personnel Credit Hours - General (Serology/Immunology): 2 hour(s) Course number 20-642425, approved through 9/1/2020 Course Overview: This course is intended to serve as an overview of the more commonly occurring mosquito-borne viral diseases around the world, including arboviruses actively causing outbreaks within the United States (eg, Zika and West Nile virus). The epidemiology, clinical manifestations, and methods utilized for laboratory diagnosis of each virus are discussed and supplementary case studies are presented. Objectives: • Review the epidemiology of the more common mosquito-borne viral diseases (excluding malaria), including dengue, chikungunya, Zika, West Nile, and yellow fever, and the encephalitis-causing viruses, including St. Louis, Eastern Equine, Western Equine, and La Crosse. • Describe the clinical manifestations and symptoms of the mosquito-borne viral diseases and encephalitis-causing viruses presented. • Identify the laboratory methods available for the diagnosis of the mosquito-borne viruses presented. • Solve case studies on the mosquito-borne viral diseases presented. How to Subscribe: • MLS & MLT Comprehensive CE Package (Includes 129 CE courses, most popular) - $95 • If u Pick Your Courses (Up to 8 CE hours) - $50 • Individual course - $20 Subscribe online, and you'll get immediate access to your purchases. Your subscription will be valid for a full year (365 days) from the date we receive payment.
| Hours : 2 | USD $95.00
Zika Virus: Overview and Laboratory Testing is organized by MediaLab, Inc. Accreditation: • P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 2 hour(s) Course number 578-030-19, approved through 6/30/2021 • Florida Board of Clinical Laboratory Personnel Credit Hours - General (Serology/Immunology): 2 hour(s) Course number 20-662139, approved through 9/1/2020 Objectives: • Understand the virology and pathogenesis of the Zika virus. • Describe the modes of transmission, symptoms, and infection risks. • Determine the risk of Zika virus infection during pregnancy and the evaluation and consequences of congenital infections. • Discuss the diagnosis of Zika virus infection using a combination of clinical symptoms, history, and diagnostic testing. • Define the main laboratory tests used for Zika virus identification, including RT-PCR, Zika IgM ELISA and plaque reduction neutralization tests (PRNT). • Review the latest Centers for Disease Control and Prevention (CDC) guidelines on Zika virus testing and diagnosis, with emphasis on the evaluation of women and newborns with peripartum Zika virus exposure. • Examine the prevention and treatment of Zika virus infections and the status of vaccine development. • Review the CDC's Zika virus testing algorithms for symptomatic and asymptomatic individuals. How to Subscribe: • MLS & MLT Comprehensive CE Package (Includes 129 CE courses, most popular) - $95 • If u Pick Your Courses (Up to 8 CE hours) - $50 • Individual course - $20 Subscribe online, and you'll get immediate access to your purchases. Your subscription will be valid for a full year (365 days) from the date we receive payment.